Hookipa Biotech AG
Hookipa Biotech AG is developing a new class of innovative immunotherapeutics and vaccines based on its proprietary Vaxwave® technology. The Vaxwave® technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases.
-
Ausrichtungen
- Therapie-Entwickler
-
Gegründet
2011 -
Aktualisiert am
30.05.2018